Home
Sengenics

Sengenics Market Share Analysis for May 2026

Transforming research and healthcare with industry-leading proteomics. Our pioneering platform provides more coverage of the proteome than any other technology

Industry: N/A

Domainsengenics.com

Year Founded1996

Employees51 - 200

Annual Revenue$15M - $25M

Sengenics

Sengenics (including company regionals)

sengenics.com

See more website traffic and engagement information

Sengenics Revenue up to May 2026 is 15M - 25M

revenue generated by Sengenics top domains

Sengenics top domains revenue over 3 years

Revenue for Sengenics top domains

sengenics.com15M - 25M

See more with Sales Intelligence

Total visits to Sengenics's top domains

Understand Sengenics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Sengenics's top domains

Analyze Sengenics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Sengenics's top domains

See how Sengenics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Sengenics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Sengenics

These are the website technologies, by industry, used by Sengenics top domains

Payment & Currencies (12)

Cart Functionality

Advertising (8)

DoubleClick

Widget (6)

Twemoji

Conversion & Analytics (3)

Google Analytics

More Technologies

11

See all

News & Signals from Sengenics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSengenics Corporation LLC. launched i-Ome Cancer, a cutting-edge research tool on Jul 30th '24.BOSTON, July 30, 2024 /PRNewswire/ - Sengenics Corporation LLC is proud to announce the launch of i-Ome Cancer, a cutting-edge research tool designed to transform cancer biomarker discovery using just a drop of blood.

NewsSengenics Corporation LLC. launched KREX protein folding technology to improve the current state of protein microarray fabrication methodology ( Sengenics | KREX on Jan 1st '08.In 2008, Sengenics introduced the patented KREX protein folding technology to improve the current state of protein microarray fabrication methodology ( Sengenics | KREX | Protein Folding Technology ).

NewsSengenics Corporation LLC. launched i-Ome Discovery, a comprehensive protein microarray platform on Oct 3rd '23.Sengenics Corporation LLC, a leader in immune response profiling to support scientific discovery and diagnostic development, today announced the launch of i-Ome Discovery, a comprehensive protein microarray platform for the analysis of autoantibodies associated with disease diagnosis and therapeutic intervention.